Apple's iPhone 6 is just weeks from release and will kick off Apple's new health care strategy. Google's working on its own plan to chase the health care market too.
Apple’s iPhone 6 is just weeks from release and will kick off Apple’s new health care strategy. Google’s working on its own plan to chase the health care market too.
The two companies’ moves have gotten plenty of buzz. (The power of the iPhone alone guarantees that Apple’s strategy will be closely scrutinized.)
But is another tech company — Amazon — about to make its own important play for health care business?
There’s reason to wonder: Amazon executives recently held a meeting with top FDA officials, Darius Tahir reports in an
for
Modern Healthcare
.
Source: Forbes
Read the full story:
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Homelessness Compounds Hospital Stay Challenges: Study Reveals Prolonged Discharge Struggles
March 28th 2024In this investigation, outcomes of interest were morbidity rate and length of hospital stay or a traumatic injury among a homeless population, and whether age and/or injury severity had an influence on that relationship—with implications for improving the discharge process for these patients.
Read More
FDA Approves Vadadustat for Anemia in Patients With CKD Undergoing Dialysis
March 28th 2024The FDA approved vadadustat (Vafseo), an oral medication, to treat anemia in adult patients with chronic kidney disease (CKD) on dialysis for at least 3 months. This fills a need for a new treatment option as anemia is common in these patients and can significantly impact their quality of life.
Read More